Detalhe da pesquisa
1.
Pharmacokinetics and tolerance of repeated oral administration of 5-fluorocytosine in healthy dogs.
BMC Vet Res
; 17(1): 220, 2021 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34154593
2.
By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
J Virol
; 93(11)2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30918073
3.
Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs.
BMC Vet Res
; 16(1): 307, 2020 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32843040
4.
Polymeric Cups for Cavitation-mediated Delivery of Oncolytic Vaccinia Virus.
Mol Ther
; 24(9): 1627-33, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27375160
5.
Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors.
Mol Ther Oncolytics
; 30: 103-116, 2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635744
6.
Direct imaging and automatic analysis in tumor-on-chip reveal cooperative antitumoral activity of immune cells and oncolytic vaccinia virus.
Biosens Bioelectron
; 215: 114571, 2022 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932554
7.
Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination.
Clin Transl Immunology
; 11(5): e1392, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35573979
8.
Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs.
Sci Rep
; 11(1): 2209, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33500518
9.
High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma.
Mol Ther Oncolytics
; 18: 573-578, 2020 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32995481
10.
Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer.
Mol Ther Oncolytics
; 19: 57-66, 2020 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33072863
11.
Fluorescent Tagged Vaccinia Virus Genome Allows Rapid and Efficient Measurement of Oncolytic Potential and Discovery of Oncolytic Modulators.
Biomedicines
; 8(12)2020 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256205
12.
The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism.
Mol Ther Oncolytics
; 14: 1-14, 2019 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31011628
13.
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy.
Mol Ther Oncolytics
; 14: 246-252, 2019 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31428674
14.
Oncolytic properties of non-vaccinia poxviruses.
Oncotarget
; 9(89): 35891-35906, 2018 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30542506
15.
Ultrasound-mediated cavitation does not decrease the activity of small molecule, antibody or viral-based medicines.
Int J Nanomedicine
; 13: 337-349, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29391793
16.
Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency.
Cancers (Basel)
; 10(7)2018 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29996551
17.
Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.
Oncoimmunology
; 7(3): e1407897, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29399408
18.
Cowpox Virus: A New and Armed Oncolytic Poxvirus.
Mol Ther Oncolytics
; 7: 1-11, 2017 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28951885
19.
Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment.
Oncoimmunology
; 5(2): e1080414, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27057460
20.
Trial Watch-Oncolytic viruses and cancer therapy.
Oncoimmunology
; 5(2): e1117740, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27057469